Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 1516 AL 1530

The Effect of Dopaminergic Medication on Impulse Control and Compulsive Behaviour: A Translational Perspective

Wolfschlag M, Espa E, Hauer KO, Timpka J, Smith R, Odin P, Cenci MA, Håkansson A.

Basic Clin Pharmacol Toxicol. 2026 Jul;139(1):e70264. doi: 10.1111/bcpt.70264.

Anti-Neuroinflammatory and Neuroprotective Effects of Caffeic Acid in Experimental Models of Neurodegeneration: A Systematic Review and Meta-Analysis

Bhat R, Greeny A, Viswanatha GL, Mudgal J, Hanumanthappa S, Krishnadas N.

J Biochem Mol Toxicol. 2026 Jun;40(6):e70959. doi: 10.1002/jbt.70959.

Essential Tremor and Digital Biomarkers: A Scoping Review Using the TRACE Framework to Map Readiness for Clinical Trials and Routine Practice

Ledingham D, Macerollo A, Pavese N.

Tremor Other Hyperkinet Mov (N Y). 2026 Jun 8;16:39. doi: 10.5334/tohm.1205. eCollection 2026.

Exercise Intervention for REM Sleep Behavior Disorder in Parkinson's Disease: Mechanisms and Implications for Neurorehabilitation

Qiu X, Wang Z, Xu R, Hu Y, Le W.

CNS Neurosci Ther. 2026 Jun;32(6):e70991. doi: 10.1002/cns.70991.

Epigallocatechin-3-gallate (EGCG) as a molecular chaperone and network rebalancer in neurodegenerative diseases

Farah H, Ahmed MH, Al-Hasnaawei S, Malathi H, Mishra S, Nanda A, Arora V, Chauhan AS.

Inflammopharmacology. 2026 Jul;34(7):4537-4550. doi: 10.1007/s10787-026-02291-6. Epub 2026 Jun 15.

Glycated haemoglobin (HbA1c) levels and motor symptoms in Parkinson's disease

Choudhary N, Seervi N, Bhargava A, Khichar S.

Indian J Med Res. 2026 Jun;163(6):786-792. doi: 10.25259/IJMR_2218_2025.

Current progress in the use of pyrazole-containing compounds for neuroprotection as a strategy to counteract neurodegeneration

Bastos IM, Moreira DR, Rebelo S, Silva VLM.

Biochem Pharmacol. 2026 Sep;251(Pt 2):118161. doi: 10.1016/j.bcp.2026.118161. Epub 2026 Jun 15.

Adaptive deep brain stimulation for dynamic gait control in Parkinson's disease: a randomized feasibility trial

Louie KH, Balakid JP, Bath JE, Song S, Fekri Azgomi H, Marks JH, Choi JT, Starr PA, Wang DD.

Nat Med. 2026 Aug;32(8):2803-2814. doi: 10.1038/s41591-026-04434-2. Epub 2026 Jun 15.

The lung-brain axis in neurodegeneration: inflammatory, immune, and vascular mechanisms with therapeutic implications

Al-Shami AS, Anwar MM.

Inflammopharmacology. 2026 Jul;34(7):4483-4513. doi: 10.1007/s10787-026-02285-4. Epub 2026 Jun 16.

Deep brain stimulation in alpha-synuclein models of Parkinson's disease: Bridging the translational gap

Kondrataviciute L, Weber H, Kapadia M, Aguirre-Padilla DH, Fauser M, Valiante TA, Hutchison WD, Milosevic L, Storch A, Kalia LV, Kalia SK.

J Parkinsons Dis. 2026 Jun 16:1877718X261459876. doi: 10.1177/1877718X261459876. Online ahead of print.

The Noradrenergic Brain in Parkinson's Disease

Pasquini J, Palermo G, Pavese N, Ceravolo R.

Curr Neurol Neurosci Rep. 2026 Jun 16;26(1):30. doi: 10.1007/s11910-026-01499-x.

Fecal Microbiota Transplantation in Parkinson Disease: A Systematic Review, Meta-Analysis, and Meta-Regression

Pereira MAOM, Tudella GCN, Klostermann AU, Ohannesian VA, Gonçalves OR, da Silva RO, Andrade Fernandes JV, Ahmed A, Alencar ABB, de Morais STA, Almeida KJ.

Neurology. 2026 Jul 14;107(1):e218175. doi: 10.1212/WNL.0000000000218175. Epub 2026 Jun 16.

The Prodromal Synucleinopathy Rating Scale: An Assessment in Patients With REM Sleep Behavior Disorder

Boeve BF, Nie Y, Lu R, De La Cruz H, Avidan AY, Bliwise DL, Campbell MC, Criswell SR, Davis AA, Duff K, Elliott J, Ferman TJ, Fields JA, Forsberg LK, Gagnon JF, Howell M, Huddleston DE, Lim MM, Locke J, McCarter SJ, McLeland J, Miglis MG, Miyagawa T, Neilson LE, Nichols K, Pelletier A, Schenck CH, Louis EKS, Sum-Ping O, Trotti LM, Videnovic A, Xiong C, Postuma R, Ju YS; NAPS Consortium.

Neurology. 2026 Jul 14;107(1):e218176. doi: 10.1212/WNL.0000000000218176. Epub 2026 Jun 16.

Lupeol in neurodegenerative and neuropsychiatric disorders: Mechanisms and translational perspectives

Al-Abboodi ARR, Azman KF.

Biomed Pharmacother. 2026 Aug;201:119673. doi: 10.1016/j.biopha.2026.119673. Epub 2026 Jun 16.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias